Novartis AG (Novartis AG) 5-Year EBITDA Growth Rate

: -0.50% (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

Novartis AG's EBITDA per Share for the three months ended in Dec. 2023 was $2.02.

During the past 12 months, Novartis AG's average EBITDA Per Share Growth Rate was 21.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 4.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -0.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Novartis AG was 13.70% per year. The lowest was -4.90% per year. And the median was 3.10% per year.

Competitive Comparison

For the Drug Manufacturers - General subindustry, Novartis AG's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novartis AG 5-Year EBITDA Growth Rate Distribution

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Novartis AG's 5-Year EBITDA Growth Rate falls into.

Novartis AG 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Novartis AG (NYSE:NVS) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Novartis AG 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Novartis AG's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG (Novartis AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (NYSE:NVS) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.